HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calpain-2 promotes MKP-1 expression protecting cardiomyocytes in both in vitro and in vivo mouse models of doxorubicin-induced cardiotoxicity.

Abstract
We recently reported that doxorubicin decreased the expression of calpain-1/2, while inhibition of calpain activity promoted doxorubicin-induced cardiac injury in mice. In this study, we investigated whether and how elevation of calpain-2 could affect doxorubicin-triggered cardiac injury. Transgenic mice with inducible cardiomyocyte-specific expression of calpain-2 were generated. An acute cardiotoxicity was induced in both transgenic mice and their relevant wild-type littermates by injection of a single dose of doxorubicin (20 mg/kg) and cardiac injury was analyzed 5 days after doxorubicin injection. Cardiomyocyte-specific up-regulation of calpain-2 did not induce any adverse cardiac phenotypes under physiological conditions by age 3 months, but significantly reduced myocardial injury and improved myocardial function in doxorubicin-treated mice. Cardiac protection of calpain-2 up-regulation was also observed in a mouse model of chronic doxorubicin cardiotoxicity. Up-regulation of calpain-2 increased the protein levels of mitogen activated protein kinase phosphatase-1 (MKP-1) in cultured mouse cardiomyocytes and heart tissues. Over-expression of MKP-1 prevented, whereas knockdown of MKP-1 augmented doxorubicin-induced apoptosis in cultured cardiomyocytes. Moreover, knockdown of MKP-1 offset calpain-2-elicited protective effects against doxorubicin-induced injury in cultured cardiomyocytes. Mechanistically, up-regulation of calpain-2 reduced the protein levels of phosphatase and tensin homolog and consequently promoted Akt activation, leading to increased MKP-1 protein steady-state levels by inhibiting its degradation. Collectively, this study reveals a new role of calpain-2 in promoting MKP-1 expression via phosphatase and tensin homolog/Akt signaling. This study also suggests that calpain-2/MKP-1 signaling may represent new therapeutic targets for doxorubicin-induced cardiac injury.
AuthorsDong Zheng, Zhaoliang Su, Yi Zhang, Rui Ni, Guo-Chang Fan, Jeffrey Robbins, Long-Sheng Song, Jianmin Li, Tianqing Peng
JournalArchives of toxicology (Arch Toxicol) Vol. 93 Issue 4 Pg. 1051-1065 (04 2019) ISSN: 1432-0738 [Electronic] Germany
PMID30810770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Doxorubicin
  • Dual Specificity Phosphatase 1
  • Dusp1 protein, mouse
  • Calpain
  • Capn2 protein, mouse
Topics
  • Animals
  • Apoptosis (drug effects, genetics)
  • Calpain (genetics, metabolism)
  • Cardiotoxicity
  • Cells, Cultured
  • Doxorubicin (toxicity)
  • Dual Specificity Phosphatase 1 (genetics)
  • Gene Expression (drug effects)
  • Heart (drug effects)
  • Mice, Transgenic
  • Myocardium (metabolism, pathology)
  • Myocytes, Cardiac (drug effects, metabolism, pathology)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: